10% Owner ORBIMED ADVISORS LLC sells entire 73.11M share stake in XTNT for $30.7M at $0.42, exiting completely
ORBIMED ADVISORS LLC liquidated its complete equity stake in Xtant Medical, selling 73,114,592 shares across 2 separate transactions on 2025-04-10 for $30,708,128.64 ($0.42 blended average), reducing holdings from 73.11M to 0 shares (-100.0% vs pre-transaction holdings). This represents a total exit by a major shareholder at a price 5.0% below the current market price of $0.40 and 55.8% below the 52-week high of $0.95. The timing occurs as the stock is down 16.7% over 30 days and 21.0% over 90 days, while the company reports ongoing unprofitability (latest quarter net income: $-5,024,000.00) despite 28.4% annual revenue growth. ORBIMED's cross-ticker sell track record shows 18 prior dispositions with an average 30-day post-sale return of -4.2%, suggesting a pattern of selling positions that do not subsequently appreciate.